Rahul Loungani, MD

Start Year
2017

Education and Training

Medical School
Medical University of South Carolina

Residency
The Johns Hopkins Hospital

Career and Research Goals

Clinical research in advanced heart failure

Honors, awards and distinctions

  • Daniel Baker Award, Department of Medicine, Johns Hopkins Hospital
  • Henry Tracy Ivy Award, Medical University of South Carolina

Fellow Perspective

Tell us briefly about your background before fellowship?
I earned my MD at the Medical University of South Carolina in Charleston SC and then completed my internal medicine training in the Osler Medical Training Program at the Johns Hopkins Hospital

What are your career plans in cardiology?
I plan on pursuing an advanced fellowship in heart failure. Part of my love for cardiology comes from my fascination with heart failure pathophysiology. I hope to be able to utilize both invasive and non-invasive hemodynamic data to better profile and phenotype atypical populations of cardiomyopathy.

Why did you choose Duke for your fellowship training?
My goal for cardiovascular fellowship training is first, and foremost, to be an excellent clinical cardiologist. Our clinical training, particularly our training in the CCU, is quite rigorous. We are primarily responsible for caring for the sickest patients not only in the hospital, but around the state, that are transferred in for our care. However, I wanted to be at an institution that would be willing to teach me research skills, connect me with the right mentors, and provide a breadth of research opportunities as I discovered which niche of cardiology suited me most. The Duke Cardiology Fellowship certainly encompasses all these traits.

What advice might you offer residents looking at fellowship programs?
While it’s important to choose a fellowship program that matches your specific sets of interest and your vision for your career, be aware that sometimes interests can change, particularly as you are exposed to areas of cardiology that you have not really experienced before. In that scenario, it’s best to choose a program that’s has excellent opportunities across a breadth of clinical and research areas. I felt confident that no matter what path I decided to take or what research interests I developed, I could find what I needed in the Duke cardiology program.

From your experience in fellowship, what have you learned about training at Duke?
The volume of cardiovascular disease here is beyond even what I expected, and there are leaders here in every aspect of cardiology. I’ve also learned that my co-fellows are exceptionally bright; I have no doubt they will be leaders in the field of cardiology, and some of them are already on their way to being so. Despite all of this, they’re all humble, collegial, and extremely welcoming!

How is your life in the Triangle area outside of work?
Great! My wife and I were able to recently purchase a house which was very affordable. We frequently enjoy the many great restaurants in downtown Durham. We’ve been able to travel to the beautiful North Carolina beaches which are close-by, and have spent time exploring the other cities in the Triangle – Chapel Hill and Raleigh – each of which has its own unique vibe.

Publications

Loungani, Rahul S., Michael R. Rehorn, L Kristin Newby, Jason N. Katz, Igor Klem, Robert J. Mentz, W Schuyler Jones, et al. “A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response.” Am Heart J 225 (July 2020): 3–9. https://doi.org/10.1016/j.ahj.2020.04.024.

PMID
32417526
Full Text

Black-Maier, Eric, Robert K. Lewis, Michael Rehorn, Rahul Loungani, Daniel J. Friedman, Camille Frazier-Mills, Kevin P. Jackson, et al. “Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.” J Cardiovasc Electrophysiol 31, no. 6 (June 2020): 1509–18. https://doi.org/10.1111/jce.14487.

PMID
32275340
Full Text

Loungani, Rahul S., Michael R. Rehorn, Kyle R. Geurink, Amanda C. Coniglio, Eric Black-Maier, Sean D. Pokorney, and Michel G. Khouri. “Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter.” Am Heart J 222 (April 2020): 26–29. https://doi.org/10.1016/j.ahj.2020.01.002.

PMID
32004797
Full Text

Loungani, Rahul S., and G Michael Felker. “Is Resistance Futile?: Addressing Diuretic Resistance During Hospitalization for Heart Failure.” Jacc Heart Fail 8, no. 3 (March 2020): 169–71. https://doi.org/10.1016/j.jchf.2019.10.008.

PMID
31926852
Full Text

Loungani, Rahul, Michael Rehorn, Sean Pokorney, and Michel Khouri. “VENTRICULAR ARRHYTHMIA BURDEN IN PATIENTS WITH CARDIAC AMYLOIDOSIS.” Journal of the American College of Cardiology 75, no. 11 (March 2020): 433–433. https://doi.org/10.1016/s0735-1097(20)31060-3.

Full Text

Rehorn, Michael, Rahul Loungani, Sean Pokorney, and Michel Khouri. “PROGRESSION OF ATRIAL ARRYTHMIAS AND CONDUCTION DISEASE IN PATIENTS WITH CARDIAC AMYLOIDOSIS.” Journal of the American College of Cardiology 75, no. 11 (March 2020): 493–493. https://doi.org/10.1016/s0735-1097(20)31120-7.

Full Text

Feng, Kent Y., Rahul S. Loungani, Vishal N. Rao, Chetan B. Patel, Michel G. Khouri, G Michael Felker, and Adam D. DeVore. “Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy.” Jacc: Cardiooncology 1, no. 2 (December 2019): 273–79. https://doi.org/10.1016/j.jaccao.2019.11.006.

Full Text

Kochar, Ajar, Jennifer Rymer, Zainab Samad, and Zainab Duke Cardiovascular Education Group. “Disrupting Fellow Education Through Group Texting: WhatsApp in Fellow Education?” J Am Coll Cardiol 72, no. 25 (December 25, 2018): 3366–69. https://doi.org/10.1016/j.jacc.2018.11.007.

PMID
30573034
Full Text

Fudim, Marat, Rahul Loungani, Shannon M. Doerfler, Adrian Coles, Stephen J. Greene, Lauren B. Cooper, Mona Fiuzat, Christopher M. O’Connor, Joseph G. Rogers, and Robert J. Mentz. “Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial.” Am Heart J 204 (October 2018): 163–73. https://doi.org/10.1016/j.ahj.2018.07.019.

PMID
30121018
Full Text

Houston, Brian A., Rohan J. Kalathiya, Steven Hsu, Rahul Loungani, Mary E. Davis, Samuel T. Coffin, Nicholas Haglund, et al. “Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis.” J Heart Lung Transplant 35, no. 7 (July 2016): 868–76. https://doi.org/10.1016/j.healun.2016.01.1225.

PMID
27041496
Full Text

Pages